Description

Ninlaro is a medication used in the treatment of multiple myeloma, a type of blood cancer. It contains the active ingredient ixazomib, which is a proteasome inhibitor that helps to slow down the growth of cancer cells.

Interpreter Notes

Interpreters should be aware that Ninlaro may be referred to by its generic name, ixazomib, in some contexts. It is important to maintain a formal register when discussing this medication, as it is used in serious medical conditions. Avoid colloquial terms or regional variations when interpreting in clinical settings.

Example Sentences

EN: The doctor prescribed Ninlaro as part of the treatment plan for the patient's multiple myeloma.

ES: El médico recetó Ninlaro como parte del plan de tratamiento para el mieloma múltiple del paciente.

Common Interpreter Mistakes

Confusing Ninlaro with other cancer medications; mispronouncing 'Ninlaro' as 'Ninlaro' with incorrect emphasis; mixing up ixazomib with similar-sounding drugs.